BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18181726)

  • 1. Probiotics in the United States.
    Vanderhoof JA; Young R
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S67-72; discussion S144-51. PubMed ID: 18181726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical research on probiotics: the interface between science and regulation.
    Tamayo C
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S101-3; discussion S144-51. PubMed ID: 18181711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
    Mattia A; Merker R
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S115-8; discussion S144-51. PubMed ID: 18181714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe and efficacious probiotics: what are they?
    Reid G
    Trends Microbiol; 2006 Aug; 14(8):348-52. PubMed ID: 16809039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics: definition, sources, selection, and uses.
    Sanders ME
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S58-61; discussion S144-51. PubMed ID: 18181724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current marketplace for probiotics: a Japanese perspective.
    Amagase H
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety of probiotics--a review].
    Zhang Z; Liu C; Guo X
    Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):257-61. PubMed ID: 18438012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic and therapeutic uses of probiotics: a review.
    Kopp-Hoolihan L
    J Am Diet Assoc; 2001 Feb; 101(2):229-38; quiz 239-41. PubMed ID: 11271697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics: facts and myths.
    Senok AC; Ismaeel AY; Botta GA
    Clin Microbiol Infect; 2005 Dec; 11(12):958-66. PubMed ID: 16307549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of probiotics.
    Donohue DC
    Asia Pac J Clin Nutr; 2006; 15(4):563-9. PubMed ID: 17077077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Probiotics--possibilities and limitations of their application in food, animal feed, and in pharmaceutical preparations for men and animals].
    Reuter G
    Berl Munch Tierarztl Wochenschr; 2001; 114(11-12):410-9. PubMed ID: 11766268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics--the friendly bacteria with market potential in global market.
    Khan SH; Ansari FA
    Pak J Pharm Sci; 2007 Jan; 20(1):76-82. PubMed ID: 17337434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical testing in the development of probiotics: a regulatory perspective with Bacillus strains as an example.
    Sorokulova I
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S92-5; discussion S144-51. PubMed ID: 18181731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of probiotics according to the international organizations (FAO/WHO)].
    LiaskovskiÄ­ TM; PodgorskiÄ­ VS
    Mikrobiol Z; 2005; 67(6):104-12. PubMed ID: 16493892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
    Saxelin M
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of probiotics as biologic drugs.
    Hoffman FA
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S125-7; discussion S144-51. PubMed ID: 18181717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics: time for a dose of realism.
    Tannock GW
    Curr Issues Intest Microbiol; 2003 Sep; 4(2):33-42. PubMed ID: 14503687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating the safety of probiotics--the European approach.
    von Wright A
    Curr Pharm Des; 2005; 11(1):17-23. PubMed ID: 15638749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.